| Financial Year |
March 31 2022 |
| Monetary Funds |
28,203,292,416.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,222,259.14 |
| Accounts Receivable |
1,539,920,387.84 |
| Advances to Suppliers |
1,026,423,743.03 |
| Other Receivables |
298,570,503.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
8,567,040.00 |
| Inventories |
8,647,957,831.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
114,825,391.38 |
| Other Current Assets |
1,261,175,320.47 |
| Total Current Assets |
49,771,136,212.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
222,590,757.79 |
| Long-term Equity Investment |
4,901,495,299.97 |
| Investment Properties |
148,325,745.70 |
| Fixed Assetes |
8,911,457,997.33 |
| Under-construction Projects |
1,112,116,406.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,787,383,535.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
283,558.64 |
| Deferred Income Tax Assets |
1,695,909,246.30 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
19,913,607,165.41 |
| Total Assets |
69,684,743,378.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,483,634,740.16 |
| Accounts Payable |
16,325,284,847.92 |
| Accounts Received In Advance |
377,972.03 |
| Employee Compensation Payable |
493,739,141.88 |
| Taxes Payable |
152,995,420.49 |
| Interest Payable |
-- |
| Dividend Payable |
171,500.02 |
| Other payables |
6,987,117,986.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,098,162.09 |
| Other Current Liabilities |
209,738,118.26 |
| Sub-Total of Current Liabilities |
37,841,260,695.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,279,784,833.73 |
| Deferred Income Tax Liabilities |
377,336,284.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,112,641,895.95 |
| Total Liabilities |
42,953,902,591.88 |
| Paid-In Capital(Or Share Stock) |
4,654,114,613.00 |
| Capital Surplus |
10,454,930,397.02 |
| Surplus Reserve |
2,742,214,904.83 |
| LESS:Treasury Stock |
310,460,486.38 |
| Undistributed Profits |
8,886,563,690.45 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,730,840,786.13 |
| Owner's Equity（Stockholder's Equity） |
26,730,840,786.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
69,684,743,378.01 |
